Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Recent data indicate that more than 65% of patients with major depressive disorder (MDD) fail to achieve remission. This article reviews research on the current understanding and management of residual symptoms, i.e., subthreshold depressive symptoms present after recovery from a major depressive episode. DATA SOURCES: MEDLINE (1966 to June 2006) was searched using combinations of the following search terms: major depressive disorder, residual symptoms, remission, response, tachyphylaxis, antidepressant, algorithm, treatment, responsiveness, serotonin, norepinephrine, and dopamine. STUDY SELECTION: All relevant articles that were published in English and reported original study data related to residual symptoms in MDD were included. DATA EXTRACTION: Studies were examined for data related to the prevalence, presentation, consequences, treatment, and neurobiological underpinnings of residual symptoms associated with MDD. DATA SYNTHESIS: Residual symptoms are common among patients treated for MDD who do not achieve full remission. Incomplete remission is associated with increased risk of relapse, suicide, functional impairment, and higher use of health care resources. Several factors, including "downstream" neurochemical mechanisms and clinical factors such as lack of adherence, contribute to the high prevalence of residual symptoms. Various clinical strategies, including switching and substitution antidepressant therapies, are used to address unresolved depressive symptoms. Individual differences in therapeutic response contribute to inadequate treatment and are linked to numerous clinical and neurobiological factors, including noncompliance, underdosing, intolerance, disturbances in neural circuitry, and genetic variability in neurotransmitters. CONCLUSIONS: Future research is needed to more precisely characterize residual symptoms and their underlying biochemical and molecular mechanisms in order to develop more effective treatment methods.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three broad disease models proposed by the literature to explain treatment resistance, summarised in Figure 5 (see eAppendix 3 for search details). 48–51”
From Treatment resistance in psychiatry: state of the art and new directions (2022) · cites this paper as [49]
Citations
Cites
Still being checked.
Cited by
Items 101–165 of 165
Raab‐Graham, K. F., Workman, E. R., Namjoshi, S. V., & Niere, F. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.020 · Cited by 13
Hellwig, S., Frings, L., Masuch, A., Vach, W., Domschke, K., Normann, C., & Meyer, P. T. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1863-7 · Cited by 13
The relationship between insomnia and major depressive disorder: a chicken and egg situation?
Güleç, M., Özcan, H., Oral, E., Selvı, Y., & Aydın, A. (2012) · Journal of Mood Disorders · doi:10.5455/jmood.20120208025502 · Cited by 12
Number of illness episodes as predictor of residual symptoms in major depressive disorder
Serafini, G., Nebbia, J., Cipriani, N., Conigliaro, C., Erbuto, D., Pompili, M., & Amore, M. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.026 · Cited by 11
Gönül, A. S., Çetinkalp, Ş., Tunay, S., Polat, I., Şimşek, F., Özkul, B., Kizilates-Evin, G., Erdoğan, Y., & Coburn, K. L. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.11.001 · Cited by 11
Wang, Q., Wu, Z., Xiang, H., Zhou, Y., Qin, X., & Tian, J. (2023) · Food & Function · doi:10.1039/d3fo01876h · Cited by 11
Beckmann, F., Seidenbecher, S., Metzger, C. D., Gescher, D. M., Carballedo, A., Tozzi, L., O’Keane, V., & Frodl, T. (2022) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2022.111440 · Cited by 11
Empowering Adults in Recovery from Depression: A Community-Based Self-Management Group Program
Houle, J., Gauvin, G., Collard, B., Meunier, S., Frasure‐Smith, N., Lespérance, F., Villaggi, B., Roberge, P., Provencher, M. D., & Lambert, J. (2016) · Canadian Journal of Community Mental Health · doi:10.7870/cjcmh-2016-033 · Cited by 10
Katzman, M. A., Anand, L., Furtado, M., & Chokka, P. R. (2014) · Psychiatry Research · doi:10.1016/s0165-1781(14)70002-2 · Cited by 10
Beckmann, F., Gruber, H., Seidenbecher, S., Schirmer, S. T., Metzger, C. D., Tozzi, L., & Frodl, T. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16249 · Cited by 10
Davoudi, M., Abdelrahman, R. M., Fakhrou, A. A., & Pourshahbaz, A. (2024) · Cognitive Therapy and Research · doi:10.1007/s10608-024-10529-2 · Cited by 10
Comparing outcomes of adjunctive treatment in depression: Aripiprazole versus Bupropion
Nasr, S. J., Wendt, B., Popli, A., & Crayton, J. W. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.019 · Cited by 10
Chappell, K., Tayeb, A. E. K. A., Colle, R., Bouligand, J., El‐Asmar, K., Gressier, F., Trabado, S., David, D. J. P., Fève, B., Becquemont, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.974570 · Cited by 9
Uban, K. A., Bodnar, T. S., Butts, K. A., Sliwowska, J. H., Comeau, W. L., & Weinberg, J. (2010) · Health care and disease management · doi:10.1002/9783527632510.ch5 · Cited by 11
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K. J., Lux, L. J., Noord, M. V., Mager, U., Gaynes, B. N., Thieda, P., Strobelberger, M., et al. (2011) · Cited by 8
Stamouli, S. S., Yfantis, A., Lambousis, E., Liakouras, A., Lagari, V., Tzanakaki, M., Giailoglou, D., Legault, M., & Parashos, I. A. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902810375 · Cited by 7
Hung, C., Liu, C., Wang, S., & Yang, C. (2013) · Psychopathology · doi:10.1159/000348583 · Cited by 7
Sun, J., Shen, C., Liu, X.-M., & Liu, P.-Z. (2023) · Psychiatry Investigation · doi:10.30773/pi.2021.0372 · Cited by 7
P2RX7 Dynamics in CNS Disorders: Molecular Insights and Therapeutic Perspectives
Mithaiwala, A., Thakur, J., & Godad, A. P. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05330-5 · Cited by 5
Bareš, M., Novák, T., Kopeček, M., Stopková, P., & Höschl, C. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.492226 · Cited by 4
Major Depresif Bozukluk Tedavisinde Yetersiz Yanıtın Yönetimi ve Yeni Tedavi Seçenekleri
Karamustafalıoğlu, O., & Yavuz, B. G. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2011.11790745 · Cited by 4
Klinedinst, N. J., Clark, P. C., & Dunbar, S. B. (2013) · Rehabilitation Psychology · doi:10.1037/a0033005 · Cited by 4
Mwansisya, T. E. (2016) · International Journal of Emergency Mental Health and Human Resilience · doi:10.4172/1522-4821.1000307 · Cited by 4
Depressione resistente al trattamento: stato dell’arte. Parte I. Nosografia e clinica
Luchini, F., Cosentino, L., Pensabene, L., Mauri, M., & Lattanzi, L. (2014) · Rivista di psichiatria · doi:10.1708/1668.18260 · Cited by 4
Chappell, K., Colle, R., Tayeb, A. E. K. A., Bouligand, J., El‐Asmar, K., Deflesselle, É., Fève, B., Becquemont, L., Corruble, E., & Verstuyft, C. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110608 · Cited by 4
Lubaczewski, A. I. N. S. (2013) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000169 · Cited by 4
Kadekawa, K., Sugaya, K., MUKOYAMA, H., Sakumoto, M., Shimabukuro, H., Simabukuro, S., Matayoshi, Y., Onaga, T., Ashitomi, K., & Nishijima, S. (2014) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/luts.12079 · Cited by 4
Changer d’antidépresseur : quand, comment, pourquoi ?
Gourion, D., Galinowski, A., Baraille, L., & Picard, H. (2011) · L Encéphale · doi:10.1016/j.encep.2010.06.008 · Cited by 3
Starting the conversation about depression and suicide prevention
Gable, K. N. (2019) · Pharmacy Today · doi:10.1016/j.ptdy.2019.01.022 · Cited by 3
Animal Models for Psychological Disorders
Murison, R. C. C., & Milde, A. M. (2011) · CRC Press eBooks · doi:10.1201/b10837-4 · Cited by 3
Who Fails Appointments at Psychiatric Clinics in a General Hospital
Chow, Y.-T., Wu, L.-C., & Chen, C.-Y. (2009) · 臺灣精神醫學 · doi:10.29478/tjp.200903.0007 · Cited by 3
Chappell, K., Colle, R., Asmar, K. E., Gressier, F., Bouligand, J., Trabado, S., Fève, B., Becquemont, L., Corruble, E., & Verstuyft, C. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02765-5 · Cited by 2
Areán, P. A., & Ayalon, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09757-2_23 · Cited by 2
Fan, Q., Xue, R., Li, Y., Zhang, T., He, X., Fan, S., Li, Y., Zhong, B., Zhang, Y., & Li, J. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12567 · Cited by 2
Seizure-related neuronal injury A study of neuron-specific enolase, S-100b protein and tau protein
Palmio, J. (2009) · Tampere University Institutional Repository (Tampere University) · Cited by 2
Nomikos, G. G. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00027-8 · Cited by 1
Nancye, P. M., Husni, A., & Sawitri, D. R. (2023) · Psychiatry Nursing Journal (Jurnal Keperawatan Jiwa) · doi:10.20473/pnj.v5i2.48007 · Cited by 1
Neurobiology of psychiatric disorders
Maletic, V., & DeMuri-Maletic, B. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198746638.003.0005 · Cited by 1
Somatoforme Störungen und Somatisierungssyndrome
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_81 · Cited by 1
Kirby, J. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-21514 · Cited by 1
Bates, S. (2018) · University of Surrey Open Research repository · doi:10.15126/thesis.00849258 · Cited by 1
Huang, X., Lin, J., & Zhang, Y. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106202
Chappell, K. (2023) · theses.fr (ABES) · doi:10.70675/5afa484cz21e5z493azae47ze62ca3553104
Marazziti, D., & Mucci, F. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726867804.793557955
Kayongo, B. (2020) · EAS Journal of Pharmacy and Pharmacology · doi:10.36349/easjpp.2020.v02i06.005
Yang, L., Yan, P., Xu, Y., Hu, L., Wei, J., Song, M., Liu, W., & Mao, H. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08060-7
Hamati, R. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-24287
Prevalence of depression in schizophrenia and related disorders
Ganguly, P., Helal, A. A., Hamza, E. A., & Moustafa, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820005-6.00003-7
Alterations in adult behavior as a result of early life manipulations
Scott, K. A. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
Rashidi, Y., Barjasteh, A. H., Ilaghi, M., Pozvei, A., Soltanpour, M., Jahangiri, S., Radmanesh, M., Pourbafrani, A., Faegh, S. H. H., Bagheri, F., et al. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102741
Issues and Clues in the Pharmacological Treatment of Mood Disorders
Jollant, F., Ionita, A., & Courtet, P. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch6
Correlation of dopaminergic and serotonergic dysfunction in a rat model of Parkinson's disease /
이민경 (2015) · YUHSpace (Yonsei University Medical Library)
(2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832ae253
Long-term outcome of Treatment-Resistant Depression
Cosentino, L. (2016) · Electronic Theses and Dissertations Repository (University of Pisa)
COURSE AND OUTCOME OF TREATMENT RESISTANT DEPRESSION: A ONE-YEAR NATURALISTIC FOLLOW-UP
LOMBARDI, V. (2014) · Electronic Theses and Dissertations Repository (University of Pisa)
Santone, G., Bellantuono, C., & Psichiatrica, C. (2009) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology
Ribeiro, A. M. M. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Carceller‐Sindreu, M., & Legal, U. A. D. B. D. D. P. I. D. M. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Receptor 5-HT1A i ISRS : escurçament de la resposta antidepressiva
Canet, S. O., & Legal, U. A. D. B. D. D. P. I. D. M. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Management of inadequate response in major depressive disorder and new treatment options
Karamustafalıoğlu, O., & Yavuz, B. G. (2021) · Psychiatry and Clinical Psychopharmacology
Sarubin, N. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14084
Γεωργιόπουλος, Χ. (2010) · Νημερτής
Traditional Indigenous Medicine: An Assessment of Experiences in Expanded States of Consciousness
Almendro, M., López, E., & Horrillo, B. (2022) · Journal of consciousness exploration & research
PREVALENCE AND SYMPTOMATOLOGY OF DEPRESSION AMONGST PATIENTS WITH CNS DEPRESSANTS USE
Mustafa, S., Ilyas, M., Ahmed, B. D. S., Nadeem, A., Mahmood, F., & Naseer, S. (2026) · Genetics and Molecular Research · doi:10.4238/d340jk08
Metadata
- Authors
- Trivedi, M. H., Hollander, E., Nutt, D., & Blier, P.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Icahn School of Medicine at Mount Sinai (US)
- University of Bristol (GB)
- University of Ottawa (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-02-15
- Volume
- 69
- Issue
- 2
- Pages
- 246-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2041144155
- Cited by
- 153
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 12 · 2012: 9
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- residual depressive symptoms, major depressive disorder, incomplete remission, antidepressant response, antidepressant switching, tachyphylaxis, medication adherence, underdosing, relapse risk, suicide risk, functional disability, health care utilization, neurobiological mechanisms, serotonin, norepinephrine, dopamine, neural circuits
- MeSH terms
- Algorithms, Antidepressive Agents, Anxiety, Cognition Disorders, Decision Trees, Depression, Depressive Disorder, Dopamine, Humans, Hypothalamo-Hypophyseal System, Norepinephrine, Pituitary-Adrenal System, Serotonin, Sleep Wake Disorders, Neurotransmitter Uptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation, Adrenergic Uptake Inhibitors, Dopamine Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.